Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen.
Silvia BonannoRiccardo ZaninLuca BelloIrene TramacereVirginia BozzoniLuca CaumoManfredi FerraroSara BortolaniGianni SorarùMauro SilvestriniVeria VacchianoMara TurriRaffaella TanelRocco LiguoriMichela CocciaRenato Emilio MantegazzaTiziana MonginiElena PegoraroLorenzo MaggiPublished in: Journal of neurology (2022)
In our cohort, adult SMA patients showed a global improvement at the INQoL assessment over 14 months of nusinersen treatment. QoL assessment is relevant to SMA multidisciplinary evaluation.